Next-Generation Weight Loss Injection | Canadian Prescriber Access Only

Mounjaro (Tirzepatide) is an advanced dual hormone agonist shown to result in substantial weight loss in clinical trials. Suitable for patients meeting specific eligibility criteria, especially with coexisting diabetes or severe obesity. This medication is available only by prescription after a Canadian medical review.

• Sourced exclusively from licensed Canadian distributors
• Not available without a virtual doctor approval
• If not approved, you will receive a full refund

Prescribing and Dispensing Information:
All prescriptions are reviewed and issued by licensed Canadian clinicians based on clinical suitability and your disclosed health history. Dispensing is handled by a licensed Canadian pharmacy, in accordance with applicable federal and provincial regulations. Our clinic does not dispense medications directly and is not a licensed pharmacy.

We do not ship medications outside of Canada, and we do not engage in offshore or unlicensed distribution.